Skip to main content
. 2019 Mar 21;93(7):e02221-18. doi: 10.1128/JVI.02221-18

TABLE 2.

Serial viral passage experiments with telaprevir against EV-D68

Passage no. Selection pressure (μM)a EC50b (μM) 2Apro mutation
00 0.6 ± 0.1 No mutation
01 0.5 1.1 ± 0.4 NDc
02 1 ND ND
03 2 2.9 ± 0.2 No mutation
04 4 ND ND
05 8 >30 (resistant) N84T
a

US/KY/14-18953 (MOI, 0.1) was treated with telaprevirat the indicated concentrations.

b

EC50s were quantified using the CPE assay and are means ± SEs.

c

ND, not determined.